References
- Heher EC, Spitzer TR. Hematopoietic stem cell transplantation in patients with chronic kidney disease. Semin Nephrol 2010;30:602–614.
- Kersting S, Verdonck LF. Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction. Biol.Blood Marrow Transplant 2008;14:1312–1316.
- Badros A, Barlogie B, Siegel E, . Results of autologous stem cell transplant in multiple myeloma patients with renal failure. Br J Haematol 2001;114:822–829.
- Horwitz ME, Spasojevic I, Morris A, . Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics. Biol Blood Marrow Transplant 2007;13:1422–1426.
- Massenkeil G, Roigas J, Nagy M, . Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity. Bone Marrow Transplant 2004;34:309–316.
- Lavigne CM, Shrier DA, Ketkar M, . Tacrolimus leukoencephalopathy: a neuropathologic confirmation. Neurology 2004;63: 1132–1133.
- Lilleby K, Garcia P, Gooley T, . A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006;37:1031–1035.
- Beitinjaneh A, McKinney AM, Cao Q, . Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011;17:300–308.
- Saiz A, Graus F. Neurologic complications of hematopoietic cell transplantation. Semin Neurol 2010;30:287–295.
- Van Besien KW, Demuynck H, LeMaistre CF, . High dose melphalan allows durable engraftment of allogeneic bone marrow. Bone Marrow Transplant 1995;15:321–323.
- Singhal S, Powles R, Treleaven J, . Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women. Bone Marrow Transplant 1996;18:1049–1055.
- Badros A, Barlogie B, Siegel E, . Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning. J Clin Oncol 2002;20: 1295–1303.